A South Korea–based biopharmaceutical manufacturer focused on developing and producing biosimilar therapies for global markets. The company commercializes lower-cost alternatives to biologic drugs used in oncology, autoimmune disorders, and other chronic conditions, often partnering with internation...
No congressional trades have been disclosed for CELLTRION INC. (CLTR) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
No congressional trades found for this stock.